Find Relief in ACOR
Drug stocks are providing some relief to the bulls. Between the recent takeover of Genetnech (DNA) and this morning's good news for Amgen (AMGN), there are plenty of reasons to be bullish on pharma and biotech.
Acorda Therapeutics (ACOR) is a stock within the group that's worth watching. ACOR is plowing its way higher after a big gap up move in early June. Moves like these can follow-through for months. Look for ACOR to continue pushing higher, following its most recent breakout from a bull flag.







